Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Bristol Myers Squibb Stock Quote

Bristol Myers Squibb (NYSE: BMY)

Price as of December 1, 2023, 4:00 p.m. ET

You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Bristol Myers Squibb Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
BMY -38.06% -6.29% -1.29% +195%
S&P +11.95% +65.49% +10.59% +4,194%

Bristol Myers Squibb Company Info

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.

News & Analysis

The Fool has written over 1,300 articles on Bristol Myers Squibb.


Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.